Papers in peer-reviewed journals
1.
Innes K. Thrombolysis
for acute ischaemic stroke: core nursing
requirements. British Journal of Nursing 2003;12(7):416-24
2.
Kane I, Lindley R, Lewis S, Sandercock
P. Impact of stroke syndrome and stroke severity on the process of consent in
the Third International Stroke Trial. Cerebrovascular
Diseases 2006;21:348-52
3.
Whiteley W, Lindley R, Wardlaw J, Sandercock P. Third
International Stroke Trial.. International Journal of
Stroke. 2006;1:172-6
4.
Sandercock P, Lindley R, Wardlaw J, Protocol 06PRT/1269: Third International Stroke
Trial (IST-3).
http://www.thelancet.com/journals/lancet/misc/protocol/06PRT-1269. 2006.
5.
Wardlaw JM, Bath P, Sandercock P, Perry D, Palmer J, Watson G, Lloyd S, Geddes
J, Farrall A. The NeuroGrid
stroke exemplar clinical trial protocol..
International Journal of Stroke. 2007;2:63-9
6.
The third international stroke
trial (IST-3) of thrombolysis for acute ischaemic stroke. Sandercock P, Lindley R, Wardlaw J, Dennis M, Lewis S, Venables G, Kobayashi A, Czlonkowska A, Berge E, Bruins Slot K, Murray V, Peeters A, Hankey G, Matz K, Brainin M, Ricci S, Celani MG, Righetti E, Cantisani T, Gubitz G, Phillips S, Arauz A, Prasad K, Correia M, Lyrer P; the IST-3 collaborative group. Trials 2008 Jun 17;9(1):37. http://www.trialsjournal.com/content/9/1/37
7.
SCOPE (Stroke Complications and Outcomes Prediction Engine)
Collaborations and IST. Predicting outcome in hyper-acute stroke: validation of
a prognostic model in the Third International Stroke Trial (IST3).. Journal of Neurology Neurosurgery and Psychiatry
2008;79:397-400
8.
EPITHET-where next? Sandercock P, Wardlaw J, Dennis M, Lindley R, Hankey G, Matz K, Peeters A, Phillips S, Gubitz G, Prasad K, Ricci S, Celani MG, Righetti E, Cantisani T, Arauz A, Berge E, Slot KB, Kobayashi A, Czlonkowska A, Correia M, Murray V, Lyrer P, Venables G; IST-3 Collaborative Group. Lancet Neurology
2008 Jul;7(7):570-1; author reply 571-3.
9. Oxfordshire community stroke project clinical stroke syndrome and appearances of tissue and vascular lesions on pre-treatment CT in hyper-acute ischemic stroke among the first 510 patients in the Third International Stroke Trial (IST-3). Kobayashi A, Wardlaw J, Lindley R, Lewis S, Sandercock P, Czlonkowska A; IST-3 Collaborative Group. Stroke 2009 Mar;40(3):743-8. Epub 2009 Jan 8.
Published abstracts [ (#
number) = reference number in Cochrane Stroke Register]
1.
Chang K-C. Thrombolysis for acute ischaemic stroke: The third international stroke trial
(IST-3). [Abstract]. In: Proceedings of the 2003 Annual Meeting of
2.
Gubitz G, for the IST-3 Collaborative
Group. The Third International Stroke Trial (IST-3) - Thrombolysis
for acute ischemic stroke. [Abstract]. Journal of Stroke and Cerebrovascular Diseases 2000;9(4):208 (# 4959)
3.
Gubitz G, for the IST-3
Collaborative Group. The Third International Stroke Trial (IST-3) - Thrombolysis for acute ischemic stroke. [Abstract].
Canadian Journal of Neurological Sciences 2001;28 (Suppl
2):S28-9 (Abst.P-010) (# 5002)
4.
Gubitz GJ,
5.
Hand P, Lindley R, Wardlaw J, Sandercock P. The Third International Stroke Trial (IST-3).
[Abstract]. Stroke 2000;31(11):2866 (Abst.707)
(# 4428)
6.
Hand P, Lindley R, Wardlaw J, Sandercock P. Trials in progress: The Third International
Stroke Trial (IST-3). [Abstract]. Stroke 2000;31(11):2886 (Abst.057) (# 4488)
7.
Hand P, Lindley R, Wardlaw J, Sandercock P. The Third International Stroke Trial (IST-3).
[Abstract]. Cerebrovascular Diseases 2001;11 (Suppl 4):35 (Abst.on_24)
(# 4912)
8.
Hand PJ,
9.
Hand PJ,
10.
Hand PJ, Sandercock PA,
11.
Hankey GJ, Hand PJ,
12.
Hankey GJ, Hand PJ,
13.
Kane I, Lindley R, Sandercock P,
Lewis S, on behalf of the IST-3 Collaborative Group. Consent for thrombolysis for acute ischaemic.
stroke. [Abstract]. Cerebrovascular Diseases 2005;19
(Suppl 2):76 (Abst.15) (# 9291)
14.
Kane I, Lindley R, Sandercock P.
Consent for thrombolysis for acute ischaemic stroke.. [Abstract]. Age and Ageing 2005;34(Suppl 1):i37 (#
10906)
15.
Kane I, Sandercock P, Lindley R, Gubitz G, Phillips S. The MRC Third International Stroke
Trial (IST-3).. [Abstract]. In: Proceedings of the International Stroke
Conference 2006. Ongoing Clinical Trials
Abstracts. 16 February 2006.
16.
Kane I, Sandercock P, Lindley R,
Lewis S, on behalf of the IST-3 Collaborative Group. The Third International
Stroke Trial. Baseline characteristics of patients recruited in the expansion
phase. [Abstract]. Cerebrovascular Diseases 2005;19 (Suppl 2):29 (Abst.2)
(# 9300)
17.
Kane I, Sandercock P, Lindley R,
Lewis S. Third International Stroke Trial: characteristics of patients
recruited in the start-up phase.[Abstract]. Stroke 2004;35(1):295
(Abst.P218) (# 7853)
18.
Kane I, Sandercock P, Lindley R,
Lewis S. The Third International Stroke Trial. Baseline characteristics of
patients recruited in the expansion phase.. [Abstract]. Cerebrovascular
Diseases 2004;17(Suppl 5):110 (Abst.30) (# 8260)
19.
Kane I, Sandercock P, Lindley R,
Lewis S. The Third International Stroke Trial. Baseline characteristics of
patients recruited in the expansion phase. [Abstract]. Stroke
2004;35(6):e216 (# 8325)
20.
Kane I, Sandercock P, Lindley R,
Lewis S. The Third International Stroke Trial: baseline characteristics of
patients recruited in the expansion phase. [Abstract]. Stroke 2005;36(2):450
(Abst.P65) (# 8904)
21.
Kane I, Sandercock P, Lindley R,
Lewis S. The Third International Stroke Trial (IST-3). Thrombolysis for
acute ischaemic stroke: characteristics of patients
randomised in the expansion phase.. [Abstract]. Age and Ageing 2005;34(Suppl 1):i45 (#
10907)
22.
Kane I, Sandercock P, Lindley R.
The Third International Stroke Trial (IST-3). [Abstract]. In: Proceedings of
the 13th European Stroke Conference
(http://www.eurostroke.org/esc_ongoing_trials.asp). 13-15 May 2004.
23.
Kane I, Sandercock P, Lindley R.
The Third International Stroke Trial (IST-3). [Abstract]. Stroke
2004;35(6):e200 (# 8331)
24.
Kane I, Sandercock P, Lindley R.
Third International Stroke Trial. [Abstract]. In: Proceedings of the 29th
International Stroke Conference. 5-7 February 2004.
25.
Kane I, Sandercock P, Lindley R.
Third International Stroke Trial. [Abstract]. In: Proceedings of the
International Stroke Conference 2005. Ongoing Clinical Trials Abstracts. 2
February 2005.
26.
Kane I, Sandercock P, Lindley R.
The Third International Stroke Trial (IST-3). [Abstract]. In: Proceedings of
the 15th European Stroke Conference. 16-19 May 2006 2006.
27.
Kane I, Sandercock P. Third
International Stroke Trial (IST-3). Thrombolysis for
acute ischaemic stroke. [Abstract]. Journal of
Neurology Neurosurgery and Psychiatry 2004;75:797 (Abst.036) (# 9657)
28.
Kane I, Sandercock P. The Third
International Stroke Trial (IST-3). Thrombolysis for
acute ischaemic stroke. [Abstract]. Journal of
Neurology Neurosurgery and Psychiatry 2005;76(9):1314 (Abst.007) (# 9658)
29.
Kane I, Wardlaw J, Sandercock P, Lewis S, on behalf of the IST-3 Collaborative
Group.
30.
Kobayashi A, Bembenek J, Sandercock P, Kane I, Skowronska
M, Czlonkowska A, et al. Correlation of stroke
subtype in OCSP classification and early ischaemic
changes on CT: an analysis based on the first 389 patients from the IST-3
trial.. [Abstract]. Cerebrovascular Diseases 2006;21(Suppl 4):35 (Abst.15)
(# 10556)
31.
Kobayashi A, Sandercock P, Czlonkowska A, Lewis S, Wardlaw J.
Early ischaemic changes on CT and the OCSP
classification: an analysis of the first 389 patients from the IST-3 trial..
[Abstract]. European Journal of Neurology 2006;13(Suppl
2):26 (Abst.SC222) (# 11050)
32.
Lewis SC, Sandercock PA, Lindley
RI, Wardlaw JM, Dennis MS. The MRC Third
International Stroke trial (IST-3).. [Abstract]. In: Proceedings of the 16th
European Stroke Conference 2007. 29 May - 1 June 2007.
33.
Lindley R, Grimley R. The third
international stroke trial (IST-3): thrombolysis for
acute ischaemic stroke.. [Abstract]. Internal
Medicine Journal 2007;37(Suppl 3):A84 (Abst.P29) (# 12275)
34.
Lindley R, Hand P, Sandercock P, Wardlaw J, Lewis S, Warlow C,
Dennis M. The Third International Stroke trial (IST-3). [Abstract].
35.
In: Proceedings of the 7th International Symposium on Thrombolysis and Acute Stroke Therapy. 27-28 MAY 2002. France, Lyon:2002:71. (# 6089)
36.
Lindley R, Kobayashi A, Wardlaw J,
Sandercock P, Lewis S. Persisting hyperdense
artery sign, aspects score and risk of developing mass effect: analysis from
the first 389 patients in IST-3.. [Abstract]. Internal Medicine Journal
2007;37(Suppl 1):A7
(# 12319)
37.
Lindley R. IST-3: Thrombolysis for
acute ischaemic stroke. Unpublished. (# 3614)
38.
39.
40.
41.
42.
Maasland E, Kabboord
A, Koudstaal PJ, Dippel
DWJ. The effect of heparin on serum lipoprotein levels in patients with acute
ischemic stroke or TIA. [Abstract]. Cerebrovascular
Diseases 2002;13(Suppl 3):38 (Abst.P172) (# 6118)
43.
Ricci S, Celani MG, Righetti E,
Cantisani AT. Thrombolysis for ischaemic stroke: the IST 3 study.. [Abstract]. In: Proceedings
of the Italian Stroke Forum - Stroke 2004. 7-9 March 2004 2004.
44.
Ricci S, Celani MG, Righetti E,
Cantisani TA. International
Stroke Trial 3. Thrombolysis
for acute ischaemic stroke.. [Abstract]. In:
Proceedings of the Stroke 2003 National
Stroke Conference. 2-4 March 2003.
45.
Ricci S, Celani MG, Righetti E, Mazzoli T. Thrombolysis for acute ischaemic
stroke: the IST 3 study.. [Abstract]. In: Proceedings of the Italian Stroke
Forum - Stroke 2007. 15-16 February 2007 2007.
46.
Sandercock P, Kane I, Lindley R,
Lewis S, Dennis M, Wardlaw J. The MRC Third
International Stroke Trial (IST-3): baseline characteristics of patients
recruited in the expansion phase. [Abstract]. Journal of the Neurological
Sciences 2005;238 (Suppl 1):S439 (Abst.1331) (# 9983)
47.
Sandercock P, Kane I, Lindley R,
Lewis S, Dennis M, Wardlaw J. Baseline CT
characteristics of the first 317 patients in the MRC Third International Stroke
Trial (IST-3). [Abstract]. Journal of the Neurological Sciences 2005;238 (Suppl 1):S439-40 (Abst.1332) (# 9984).
48.
Sandercock P, Lindley R, Wardlaw J. The Third International Stroke Trial.. [Abstract].
In: Proceedings of the
49.
Sandercock P, Lindley R. Third
international stroke trial (IST 3). [Abstract]. In: Proceedings of the British
Association of Stroke Physicians. 22nd January 2003.
50.
Sandercock P, Lindley R. The third
international stroke trial (IST-3). [Abstract]. In: Proceedings of the 12th
European Stroke Conference. 21-24 May 2003.
51.
Sandercock P, Murray V, Berge E, on
behalf of the IST 3 Collaborative Group. Third International Stroke Trial (IST
3). [Abstract]. In: Proceedings of the 12th Nordic Meeting on Cerebrovascular Diseases. 17-20 September 2003.
52.
Sandercock P. Can intravenous rt-PA benefit a wider range of patients? The third
International Stroke Trial (IST-3). [Abstract]. In: Proceedings of the 7th
International Symposium on Thrombolysis and Acute
Stroke Therapy. 27-28 MAY 2002. France,
Lyon: 2002:51. (# 6086)
53.
Sandercock PA, Lindley R, Wardlaw J, Lewis S, Dennis M. The Third International
Stroke Trial (IST-3).. [Abstract]. In: Proceedings of the 17th European Stroke
Conference. 13-16 May 2008.
54.
Sandercock PA, Wardlaw
J, Lindley R, Dennis M, Lewis S. Thrombolysis for
stroke - what are the "grey areas" of uncertainty and are they
changing? Results from the third international stroke trial (IST-3)..
[Abstract]. Cerebrovascular Diseases 2008;25(Suppl 2):192 (Abst.3) (# 13579)
55.
Sandercock PAG,
56.
Sandercock PAG,
57.
Skowronska M, Bembenek
J, Sandercock P, Kane I, Kobayashi A, Czlonkowska A, et al. Persisting hyperdense
artery sign, aspects score and risk of developing mass effect: an analysis
based on the first 389 patients from the IST-3 trial.. [Abstract]. Cerebrovascular Diseases 2006;21(Suppl
4):33-4 (Abst.8) (# 10557)
58.
Venables G, Kane I, Sandercock P,
59.
Whiteley W, Sandercock
P, Lewis S, Wardlaw J, Venables
G, Lindley R. The performance of
60.
Whiteley W, Sandercock
P, Lindley R,